“Ceftolozane-Tazobactam for the treatment of nosocomial pneumonia caused by extremely resistant Pseudomonas aeruginosa”.
ESAIC Academy. Díaz Balbas E. 06/02/18; 220514; 09AP03-6
Topic: Intensive Care Medicine
CLICK HERE TO LOGIN
REGULAR CONTENT
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}